Clinical Trial: Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623252) titled 'Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected' on May 11.

Brief Summary: Optic neuritis is an important cause of acute or subacute visual loss. In clinical practice, optic neuritis must often be distinguished from other optic neuropathies, retinal diseases, anterior-segment or ocular media disorders, non-organic visual loss, and other mimics. The 2022 International Criteria for Optic Neuritis were developed to standardize the diagnosis of optic neuritis, but their performance in Chinese clinical settings, where aquaporin-4 immunoglobulin G-positive and myelin oligodendrocyte glycoprotein ...